About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 378 record(s)
Req # A-2020-000575
Adverse Reaction Reports (AERs). Report numbers: 000733028, 000732802, 000619318, E2B_01480563, E2B_02831793, E2B_02839759, E2B_02840136, 000736688, E2B_02954367.Organization: Health Canada
September 2021
Req # A-2020-000619
Adverse Reaction Reports (AERs). Report numbers: E2B_03056590, E2B_03056592, E2B_03069154, E2B_03070776.Organization: Health Canada
September 2021
Req # A-2020-000620
Adverse Reaction Reports (AERs). Report numbers: E2B_03074640, E2B_03074834, E2B_03077865.Organization: Health Canada
September 2021
Req # A-2020-000630
Electronic versions of the reviewer reports for the approval of Effexor.Organization: Health Canada
September 2021
Req # A-2020-000704
Electronic versions of the reviewer reports for the approval of Cipralex.Organization: Health Canada
September 2021
Req # A-2020-000949
All Canadian reports on undesirable events regarding Elmiron.Organization: Health Canada
September 2021
Req # A-2020-001099
Adverse Reaction Reports (AERs). Report numbers: E2B_01834589, E2B_01846499, E2B_01848064, E2B_01848863, E2B_01850501, E2B_01850517, E2B_01850538, E2B_01854965, E2B_01854994, E2B_01858104, E2B_01860818, E2B_01867019, E2B_01874209, E2B_01880132,…Organization: Health Canada
September 2021
Req # A-2020-001187
Adverse Reaction Reports (AERs). Report numbers: E2B_02453239, E2B_02453459, E2B_02453467, E2B_02453823, E2B_02454148, E2B_02454167, E2B_02454183, E2B_02454191, E2B_02454197, E2B_02454216, E2B_02454631, E2B_02454633, E2B_02454635, E2B_02454669,…Organization: Health Canada
September 2021
Req # A-2020-001214
Adverse Reaction Reports (AERs). Report numbers: E2B_02493081, E2B_02493670, E2B_02493847, E2B_02493905, E2B_02494042, E2B_02494050, E2B_02494149, E2B_02494778, E2B_02495205, E2B_02495562, E2B_02496605, E2B_02496852, E2B_02496943, E2B_02497035,…Organization: Health Canada
September 2021
Req # A-2020-001219
For Health Canada's Request for Proposal (RFP) 1000224008 - Access to Information and Privacy Consultant - Intermediate Level Consultants, copies of winning vendor proposals (as originally submitted) for each vendor.Organization: Health Canada
September 2021